$Intellia Therap(NTLA.US), $CRISPR Therap(CRSP.US) are being talked about again, and $Vor BioPharma(VOR.US), $Summit Therapeutics(SMMT.US), $Absci(ABSI.US) are also popping up on the list. As long as there are new data for the stories of gene editing and AI drug development, the market's sparks can always be reignited.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments